Elevated monocyte to high-density lipoprotein cholesterol ratio correlates with clinical severity in acute

You-Fan Peng1, Miao Luo2, Qing-Song Zhang1

  • 1Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.

Frontiers in Neurology
|October 14, 2022
PubMed

Insights

The monocyte to high-density lipoprotein cholesterol ratio (MHR) is elevated in Guillain-Barré Syndrome (GBS) patients with demyelination, particularly acute inflammatory demyelinating polyradiculoneuropathy (AIDP), and correlates with disease severity.

Area of Science:

  • Neurology
  • Biochemistry
  • Inflammation

Background:

  • The monocyte to high-density lipoprotein cholesterol ratio (MHR) is linked to nervous system disorders.
  • Its role in Guillain-Barré Syndrome (GBS) remains unclear.

Purpose of the Study:

  • To investigate the role and clinical significance of MHR in GBS patients.
  • To compare MHR levels across different GBS subtypes.

Main Methods:

  • Retrospective study of 52 GBS patients.
  • Categorization into acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor axonal neuropathy (AMAN), and acute motor sensory axonal neuropathy (AMSAN).
  • Assessment of functional status using the Hughes Functional Grading Scale (HFGS).

Main Results:

  • MHR was significantly higher in GBS patients with demyelination versus without.
  • AIDP patients exhibited elevated MHR compared to AMAN and AMSAN patients.
  • MHR positively correlated with HFGS scores in AIDP patients, indicating a link to clinical severity.

Conclusions:

  • MHR is elevated in AIDP, suggesting it reflects inflammatory processes in this GBS subtype.
  • MHR may serve as a biomarker for disease severity in AIDP.
  • Further research can explore MHR's role in GBS pathophysiology.

Related Concept Videos